Gentex Corporation GNTX
22.58
0.54
2.45%
as of 25 Sep
- Market cap
- $4.6B
- P/E
- 11.9×
Follow GNTX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.65 | 13.37 | 12.28 | 13.37 |
P/S ratio |
2.51 | 2.00 | 1.75 | 2.01 | |
P/FCF ratio |
12.88 | 10.87 | 9.73 | 10.43 | |
P/Operating CF |
41.58 | 40.39 | 33.70 | 28.56 | |
P/B ratio |
2.45 | 2.04 | 1.85 | 2.08 | |
Price to Tangible BV |
3.28 | 2.73 | 2.46 | 2.77 | |
EV/Sales |
2.44 | 1.94 | 1.69 | 1.92 | |
EV/EBITDA |
10.69 | 8.52 | 7.56 | 8.21 | |
EV/Operating CF |
9.63 | 8.38 | 7.73 | 8.47 | |
EV/FCF |
12.51 | 10.55 | 9.37 | 9.96 | |
Quick Ratio |
1.44 | 1.34 | 1.34 | 1.55 | |
Current Ratio |
2.96 | 2.91 | 2.72 | 3.04 | |
Net Debt/EBITDA |
(1.24) | (1.04) | (1.17) | (1.43) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.86 | 0.89 | 0.91 | 0.90 | |
Operating CF/Net income |
1.48 | 1.37 | 1.41 | 1.64 | |
Capex/Depreciation |
(1.37) | (0.69) | (0.66) | (0.66) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.03% | 8.26% | 7.65% | 7.56% | |
Selling, General and Administrative Expense of Revenue |
7.58% | 7.72% | 7.37% | 7.68% | |
Intangible Assets out of Total Assets |
0.21 | 0.21 | 0.21 | 0.21 | |
Share Based Compensation of Revenue |
1.59% | 1.56% | 1.54% | 1.49% | |
Graham Net Nets |
0.12 | 0.14 | 0.15 | 0.15 | |
Graham Number |
21.02 | 21.15 | 21.77 | 22.75 | |
Earnings Yield |
6.01% | 7.48% | 8.15% | 7.48% | |
Free Cash Flow Yield |
7.76% | 9.20% | 10.27% | 9.59% | |
Revenue per Share |
3.03 | 2.96 | 3.19 | 3.12 | |
Operating CF per Share |
0.68 | 0.58 | 0.65 | 0.88 | |
Capex per Share |
(0.16) | (0.08) | (0.08) | (0.09) | |
Free Cash Flow per Share |
0.52 | 0.50 | 0.57 | 0.79 | |
Cash per Share |
0.85 | 0.69 | 0.83 | 1.16 | |
Shareholders Equity per Share |
11.55 | 11.42 | 11.84 | 12.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.55 | 11.42 | 11.84 | 12.17 | |
Free Cash Flow |
111.41 | 107.98 | 120.11 | 165.76 | |
Working Capital |
774.02 | 740.89 | 763.61 | 825.81 | |
Capital Expenditures |
(35.57) | (17.52) | (16.97) | (18.82) | |
Net Current Asset Value |
724.93 | 687.67 | 713.14 | 769.60 | |
EV/EBIT |
13.37 | 10.39 | 9.18 | 9.92 | |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
15.18% | 14.20% | 14.35% | 17.32% | |
Price to Operating Income |
13.78 | 10.70 | 9.53 | 10.39 | |
| Other line items | |||||
Average Receivables |
370.51 | 331.93 | 375.05 | 379.65 | |
Average Payables |
217.32 | 208.65 | 219.77 | 226.47 | |
Average Inventory |
474.28 | 476.38 | 466.22 | 497.34 | |
Average Assets |
2,837.03 | 2,844.71 | 2,890.09 | 2,906.62 | |
Average Common Equity |
2,456.42 | 2,479.97 | 2,491.00 | 2,484.37 |
Columns are period end dates